Outsourcing

Selecting and Optimizing the Right Manufacturing Partner

Optimizing the use of partners for clinical trials depends on selecting the right contractor.

Balancing Internal Focus Against External Capabilities

Demand for outsourced services of technical R&D activities is increasing.

Developing the Best Formulation Partnership

Collaborative partnerships can foster success in formulation development projects.

Scaling Up Capacity for Cell Therapies

April 02, 2022

The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.

Understanding Pharmaceutical Compounding from Multiple Perspectives

April 02, 2022

Meeting patient needs and achieving high quality are common goals for all stakeholders.

Considering Blow-Fill-Seal for Biologic Drugs

April 02, 2022

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

NCI Awards ATCC Task Order to Provide Cancer Epidemiology Services to Research Community

April 01, 2022

Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.

Emmes Acquires Rare-Disease CRO Casimir

March 18, 2022

Emmes has acquired Casimir, marking its fourth major acquisition.

Empowering Protein Characterization

March 02, 2022

Scientists can work to overcome the challenges associated with protein characterization through empowering technologies.

Cold Comfort for Bio/Pharma

March 02, 2022

Continuous improvements in technologies and services will help cold chain operators meet future industry demand.

Selecting and Optimizing the Right Manufacturing Partner

March 02, 2022

Optimizing the use of partners for clinical trials depends on selecting the right contractor.

Insights into Outsourced vs. In-house Clinical Trial Services

March 02, 2022

Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

February 23, 2022

Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.